Edition:
United Kingdom

Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

46.00HKD
23 Feb 2018
Change (% chg)

HK$-0.10 (-0.22%)
Prev Close
HK$46.10
Open
HK$46.25
Day's High
HK$47.05
Day's Low
HK$46.00
Volume
1,649,386
Avg. Vol
3,323,860
52-wk High
HK$52.50
52-wk Low
HK$26.25

Chart for

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.84
Market Cap(Mil.): HK$97,674.18
Shares Outstanding(Mil.): 2,495.13
Dividend: 0.40
Yield (%): 1.14

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Shanghai Fosun Pharmaceutical Gets Regulatory Approval To Issue Up To 5.0 Bln Yuan Bonds

Feb 9 Shanghai Fosun Pharmaceutical Group Co Ltd :

09 Feb 2018

BRIEF-Shanghai Fosun Pharmaceutical's Unit To Invest In Amerigen Pharmaceuticals' Bonds

* SAYS UNIT SIGNS FUNDING AGREEMENT TO INVEST $10 MILLION IN AMERIGEN PHARMACEUTICALS' CONVERTIBLE BONDS Source text in Chinese: http://bit.ly/2E7YM1R Further company coverage: (Reporting by Hong Kong newsroom)

01 Feb 2018

BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials

Jan 24 Shanghai Fosun Pharmaceutical Group Co Ltd

24 Jan 2018

BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials

Jan 17 Shanghai Fosun Pharmaceutical Group Co Ltd

17 Jan 2018

BRIEF-Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm

Jan 10 Shanghai Fosun Pharmaceutical Group Co Ltd:

10 Jan 2018

Earnings vs. Estimates